drugset / Trial / NCT01183390
Anastrozole 1 mg Tablets Under Fed Conditions
RandomizedCrossoverOpen-label
Summary
The objective of this study is to evaluate the comparative bioavailability between Anastrozole 1 mg Tablets (Teva Pharmaceuticals, USA) and Arimidex® 1 mg Tablets (AstraZeneca Pharmaceuticals LP, USA), after a single-dose in healthy subjects under fed conditions.
Timeline
- Start
- 2005-09
- Primary completion
- 2005-10
- Completion
- 2005-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Anastrozole | Other / unclassified | 1 mg | — |
Indications
No indication recorded.